Answers are grounded in this paper and cite their sources.
5-Aminosalicylic acid (5-ASA) compounds occasionally exacerbate diarrhoea in patients with inflammatory bowel disease. This is thought to be due to a secretory mechanism in most cases. A patient with presumed intolerance to sulphasalazine and 5-ASA preparations who developed endoscopic and histological evidence of disease relapse after a rectal challenge with mesalazine is reported.
No takes yet. Share an insight, caveat, or question.
Kapur et al. (1995) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: